Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)

NCT03716700 is registered in ClinicalTrials.gov with Baxalta now part of Shire as lead sponsor.

NCT NCT03716700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03716700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)
Lead sponsor
Baxalta now part of Shire
Phase
Observational
Overall status
Completed
Start date
September 24, 2018
Completion date
July 23, 2020
Enrollment
126 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

primary immunodeficiency diseases (pid)